Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner

  • Diego Adhemar Jaitin (Shared first author)
  • Lorenz Adlung (Shared first author)
  • Christoph A Thaiss (Shared first author)
  • Assaf Weiner (Shared first author)
  • Baoguo Li (Shared first author)
  • Hélène Descamps
  • Patrick Lundgren
  • Camille Bleriot
  • Zhaoyuan Liu
  • Aleksandra Deczkowska
  • Hadas Keren-Shaul
  • Eyal David
  • Niv Zmora
  • Shai Meron Eldar
  • Nir Lubezky
  • Oren Shibolet
  • David A Hill
  • Mitchell A Lazar
  • Marco Colonna
  • Florent Ginhoux
  • Hagit Shapiro (Shared last author)
  • Eran Elinav (Shared last author)
  • Ido Amit (Shared last author)

Abstract

Immune cells residing in white adipose tissue have been highlighted as important factors contributing to the pathogenesis of metabolic diseases, but the molecular regulators that drive adipose tissue immune cell remodeling during obesity remain largely unknown. Using index and transcriptional single-cell sorting, we comprehensively map all adipose tissue immune populations in both mice and humans during obesity. We describe a novel and conserved Trem2+ lipid-associated macrophage (LAM) subset and identify markers, spatial localization, origin, and functional pathways associated with these cells. Genetic ablation of Trem2 in mice globally inhibits the downstream molecular LAM program, leading to adipocyte hypertrophy as well as systemic hypercholesterolemia, body fat accumulation, and glucose intolerance. These findings identify Trem2 signaling as a major pathway by which macrophages respond to loss of tissue-level lipid homeostasis, highlighting Trem2 as a key sensor of metabolic pathologies across multiple tissues and a potential therapeutic target in metabolic diseases.

Bibliographical data

Original languageEnglish
ISSN0092-8674
DOIs
Publication statusPublished - 25.07.2019
Externally publishedYes

Comment Deanary

Copyright © 2019 Elsevier Inc. All rights reserved.

PubMed 31257031